|
[1]
|
Cross, M., Ong, K.L., Culbreth, G.T., Steinmetz, J.D., Cousin, E., Lenox, H., et al. (2024) Global, Regional, and National Burden of Gout, 1990-2020, and Projections to 2050: A Systematic Analysis of the Global Burden of Disease Study 2021. The Lancet Rheumatology, 6, e507-e517. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Sun, N., Zhong, S., Li, Y., Wu, L. and Di, Y. (2016) Urate Crystals Deposition in the Feet of Overweight Juveniles and Those with Symptomatic Hyperuricemia: A Dual-Energy CT Study. Journal of Pediatric Endocrinology and Metabolism, 29, 579-583. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Lee, S.K., Jung, J., Jee, W., Lee, J.J. and Park, S. (2018) Combining Non-Contrast and Dual-Energy CT Improves Diagnosis of Early Gout. European Radiology, 29, 1267-1275. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Neilson, J., Bonnon, A., Dickson, A. and Roddy, E. (2022) Gout: Diagnosis and Management—Summary of NICE Guidance. BMJ, 378, o1754. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Dalbeth, N., Collis, J., Gregory, K., Clark, B., Robinson, E. and McQueen, F.M. (2007) Tophaceous Joint Disease Strongly Predicts Hand Function in Patients with Gout. Rheumatology, 46, 1804-1807. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Dehlin, M., Jacobsson, L. and Roddy, E. (2020) Global Epidemiology of Gout: Prevalence, Incidence, Treatment Patterns and Risk Factors. Nature Reviews Rheumatology, 16, 380-390. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Danve, A., Sehra, S.T. and Neogi, T. (2021) Role of Diet in Hyperuricemia and Gout. Best Practice & Research Clinical Rheumatology, 35, Article ID: 101723. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Zou, Z., Yang, M., Wang, Y. and Zhang, B. (2020) Gout of Ankle and Foot: DECT versus US for Crystal Detection. Clinical Rheumatology, 40, 1533-1537. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Sivera, F., Andrés, M., Carmona, L., Kydd, A.S.R., Moi, J., Seth, R., et al. (2014) Multinational Evidence-Based Recommendations for the Diagnosis and Management of Gout: Integrating Systematic Literature Review and Expert Opinion of a Broad Panel of Rheumatologists in the 3e Initiative. Annals of the Rheumatic Diseases, 73, 328-335. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Li, S., Xu, G., Liang, J., Wan, L., Cao, H. and Lin, J. (2022) The Role of Advanced Imaging in Gout Management. Frontiers in Immunology, 12, Article 811323. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Neogi, T., Jansen, T.L.T.A., Dalbeth, N., Fransen, J., Schumacher, H.R., Berendsen, D., et al. (2015) 2015 Gout Classification Criteria: An American College of Rheumatology/European League against Rheumatism Collaborative Initiative. Annals of the Rheumatic Diseases, 74, 1789-1798. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Wu, H., Xue, J., Ye, L., Zhou, Q., Shi, D. and Xu, R. (2014) The Application of Dual-Energy Computed Tomography in the Diagnosis of Acute Gouty Arthritis. Clinical Rheumatology, 33, 975-979. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Roughley, M.J., Belcher, J., Mallen, C.D. and Roddy, E. (2015) Gout and Risk of Chronic Kidney Disease and Nephrolithiasis: Meta-Analysis of Observational Studies. Arthritis Research & Therapy, 17, Article No. 90. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Stevens, P.E., Ahmed, S.B., Carrero, J.J., Foster, B., Francis, A., Hall, R.K., et al. (2024) KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105, S117-S314. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Dalbeth, N., McQueen, F.M., Singh, J.A., MacDonald, P.A., Edwards, N.L., Schumacher, H.R., et al. (2011) Tophus Measurement as an Outcome Measure for Clinical Trials of Chronic Gout: Progress and Research Priorities. The Journal of Rheumatology, 38, 1458-1461. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Bayat, S., Aati, O., Rech, J., Sapsford, M., Cavallaro, A., Lell, M., et al. (2016) Development of a Dual‐Energy Computed Tomography Scoring System for Measurement of Urate Deposition in Gout. Arthritis Care & Research, 68, 769-775. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Gaffo, A.L., Dalbeth, N., Saag, K.G., Singh, J.A., Rahn, E.J., Mudano, A.S., et al. (2018) Brief Report: Validation of a Definition of Flare in Patients with Established Gout. Arthritis & Rheumatology, 70, 462-467. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Glazebrook, K.N., Guimarães, L.S., Murthy, N.S., Black, D.F., Bongartz, T., J. Manek, N., et al. (2011) Identification of Intraarticular and Periarticular Uric Acid Crystals with Dual-Energy CT: Initial Evaluation. Radiology, 261, 516-524. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
FitzGerald, J.D., Dalbeth, N., Mikuls, T., Brignardello‐Petersen, R., Guyatt, G., Abeles, A.M., et al. (2020) 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis & Rheumatology, 72, 879-895. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Abhishek, A., Tedeschi, S.K., Pascart, T., Latourte, A., Dalbeth, N., Neogi, T., et al. (2023) The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease. Arthritis & Rheumatology, 75, 1703-1713. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Sun, M., Sun, W., Zhao, X., Li, Z., Dalbeth, N., Ji, A., et al. (2022) A Machine Learning-Assisted Model for Renal Urate Underexcretion with Genetic and Clinical Variables among Chinese Men with Gout. Arthritis Research & Therapy, 24, Article No. 67. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Latourte, A., Bardin, T. and Richette, P. (2014) Prophylaxis for Acute Gout Flares after Initiation of Urate-Lowering Therapy. Rheumatology, 53, 1920-1926. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Dalbeth, N., Pool, B., Gamble, G.D., Smith, T., Callon, K.E., McQueen, F.M., et al. (2010) Cellular Characterization of the Gouty Tophus: A Quantitative Analysis. Arthritis & Rheumatism, 62, 1549-1556. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Shen, X., Wang, C., Liang, N., Liu, Z., Li, X., Zhu, Z., et al. (2021) Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout. Arthritis & Rheumatology, 73, 1738-1748. [Google Scholar] [CrossRef] [PubMed]
|